The collaboration aims to enhance Strides’ pipeline of nasal spray products for the US market across a range of therapeutic areas. Shares of Strides Pharma Science Ltd ended at ₹879, down by ₹11.35 or 1.27%, on the BSE today (September 8).
The collaboration aims to enhance Strides’ pipeline of nasal spray products for the US market across a range of therapeutic areas. Shares of Strides Pharma Science Ltd ended at ₹879, down by ₹11.35 or 1.27%, on the BSE today (September 8).